Effects of preoperative aspirin on cardiocerebral and renal complications in non-emergent cardiac surgery patients: a sub-group and cohort study.

Authors:
Address: Department of Anesthesiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.
Journal:

Publication:
Free Text: Effects of preoperative aspirin on cardiocerebral and renal complications in non-emergent cardiac surgery patients: a sub-group and cohort study.

abstract

BACKGROUND and OBJECTIVE:

Postoperative cardiocerebral and renal complications are a major threat for patients undergoing cardiac surgery. This study was aimed to examine the effect of preoperative aspirin use on patients undergoing cardiac surgery.

METHODS:

An observational cohort study was performed on consecutive patients (n = 1879) receiving cardiac surgery at this institution. The patients excluded from the study were those with preoperative anticoagulants, unknown aspirin use, or underwent emergent cardiac surgery. Outcome events included were 30-day mortality, renal failure, readmission and a composite outcome--major adverse cardiocerebral events (MACE) that include permanent or transient stroke, coma, perioperative myocardial infarction (MI), heart block and cardiac arrest.

RESULTS:

Of all patients, 1145 patients met the inclusion criteria and were divided into two groups: those taking (n = 858) or not taking (n = 287) aspirin within 5 days preceding surgery. Patients with aspirin presented significantly more with history of hypertension, diabetes, peripheral arterial disease, previous MI, angina and older age. With propensity scores adjusted and multivariate logistic regression, however, this study showed that preoperative aspirin therapy (vs. no aspirin) significantly reduced the risk of MACE (8.4% vs. 12.5%, odds ratio [OR] 0.585, 95% CI 0.355-0.964, P = 0.035), postoperative renal failure (2.6% vs. 5.2%, OR 0.438, CI 0.203-0.945, P = 0.035) and dialysis required (0.8% vs. 3.1%, OR 0.230, CI 0.071-0.742, P = 0.014), but did not significantly reduce 30-day mortality (4.1% vs. 5.8%, OR 0.744, CI 0.376-1.472, P = 0.396) nor it increased readmissions in the patients undergoing cardiac surgery.

CONCLUSIONS:

Preoperative aspirin therapy is associated with a significant decrease in the risk of MACE and renal failure and did not increase readmissions in patients undergoing non-emergent cardiac surgery.

Related Articles
Preoperative aspirin use and outcomes in cardiac surgery patients.
Ann Surg. 2012
Preoperative aspirin use and outcomes in cardiac surgery patients.
Cao L, Young N, Liu H, Silvestry S, Sun W, Zhao N, Diehl J, Sun J. Ann Surg. 2012 Feb; 255(2):399-404.
Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
J Thorac Cardiovasc Surg. 2006
Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
Collard CD, Body SC, Shernan SK, Wang S, Mangano DT, Multicenter Study of Perioperative Ischemia (MCSPI) Research Group, Inc, Ischemia Research and Education Foundation (IREF) Investigators. J Thorac Cardiovasc Surg. 2006 Aug; 132(2):392-400.
Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery.
Circulation. 2004
Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery.
Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD. Circulation. 2004 Sep 14; 110(11 Suppl 1):II45-9.
Review Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients.
Eur Heart J. 2008
Review Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients.
Liakopoulos OJ, Choi YH, Haldenwang PL, Strauch J, Wittwer T, Dörge H, Stamm C, Wassmer G, Wahlers T. Eur Heart J. 2008 Jun; 29(12):1548-59. Epub 2008 May 27.
Review Clevidipine: a review of its use in the management of acute hypertension.
Am J Cardiovasc Drugs. 2009
Review Clevidipine: a review of its use in the management of acute hypertension.
Deeks ED, Keating GM, Keam SJ. Am J Cardiovasc Drugs. 2009; 9(2):117-34.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.